Form 8-K - Current report:
SEC Accession No. 0001104659-22-071877
Filing Date
2022-06-16
Accepted
2022-06-16 16:05:40
Documents
14
Period of Report
2022-06-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2218496d1_8k.htm   iXBRL 8-K 54412
2 EXHIBIT 10.1 tm2218496d1_ex10-1.htm EX-10.1 131634
  Complete submission text file 0001104659-22-071877.txt   437686

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cycc-20220614.xsd EX-101.SCH 3271
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cycc-20220614_def.xml EX-101.DEF 27200
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycc-20220614_lab.xml EX-101.LAB 36811
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycc-20220614_pre.xml EX-101.PRE 25822
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2218496d1_8k_htm.xml XML 5197
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 221020562
SIC: 2834 Pharmaceutical Preparations